AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $865M
1-Year Est. Return 95.13%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+95.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.08B
AUM Growth
+$244M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$28.8M

Top Sells

1
+$42.2M
2
+$17.6M
3
+$17.4M
4
KYMR icon
Kymera Therapeutics
KYMR
+$17.2M
5
AKRO
Akero Therapeutics
AKRO
+$8.39M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$228M 21.01%
8,020,136
-1,865,313
2
$216M 19.95%
5,377,362
-480,900
3
$142M 13.14%
2,287,233
-267,939
4
$106M 9.8%
6,430,257
-1,178,137
5
$103M 9.5%
10,907,859
6
$101M 9.3%
1,119,292
7
$60.3M 5.57%
58,264
8
$35.6M 3.29%
+2,092,106
9
$33.7M 3.11%
827,948
10
$19.9M 1.84%
5,836,874
11
$17.1M 1.58%
2,098,300
12
$7.13M 0.66%
418,182
13
$5.81M 0.54%
378,448
14
$5.61M 0.52%
186,979
-50,000
15
$1.07M 0.1%
992,912
-1,766,432
16
$1.05M 0.1%
607,613
-405,825
17
– –
-359,251